Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > 100% !?!? Oh my !!!

<< Previous

Bullboard Posts

Next >>

Post by mercedesmanon May 19, 2023 8:33am

369 Views

Post# 35456089

100% !?!? Oh my !!!

Did Paradigm just go from 75% to 100% Probability of Success ( I.e. assumption of FDA approval) in their latest analysis ?

A done deal?

finito?

fait accompli?

Our $ 1.60 rNPV (was $ 1.70) assumes a 100% probability of success in the trial given…and results to date that are exceeding expectations. Therefore, the $ .26 current share price suggests that the market is only giving the trial a 16% probability of success. Published industry averages have the probability for a Phase 3 trial at ~63% , or $ 1.00/sh. This increases to 77% for trials that use a biomarker for patient selection, or $ 1.23/sh. Therefore, we believe that maket is excessively discounting the potential for success in this Phase 3b trial.

Just wait until this gets distributed to the thousands of Paradigm clients eager to participate in the next late Phase 3 Trial Biotech ! Not to mention thousands of potential US investors as well !